R9 Pharma Technologies Private Limited
About R9 Pharma Technologies Private Limited
Data last updated:
R9 Pharma Technologies Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 01 February 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2022PTC159263.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramalaxmareddy Kandimalla and Thoom Srividya.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O.K Rama Laxma Reddy 11 – 13 – 189/Ssr/201 Ssr Leela Park Residency Krishi Nagar C, Hyderabad, Telangana, India – 500035.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
R9 Pharma Technologies Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressC/O.K Rama Laxma Reddy 11 – 13 – 189/Ssr/201 Ssr Leela Park Residency Krishi Nagar C, Hyderabad, Telangana, India – 500035
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of R9 Pharma Technologies Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of R9 Pharma Technologies Private Limited, buy the company report.
Board of directors of R9 Pharma Technologies Private Limited
R9 Pharma Technologies has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramalaxmareddy Kandimalla | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Thoom Srividya Also directs: Quantumgensis Private Limited, Vedicmolecule Private Limited, Vidazan Therapeutics Private Limited and 1 more | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving R9 Pharma Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for R9 Pharma Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for R9 Pharma Technologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
R9 Pharma Technologies Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ramalaxmareddy Kandimalla was appointed as Director on 01 Feb 2022.
Frequently asked questions
R9 Pharma Technologies is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 01 February 2022 (4+ years old) and is registered under CIN U24290TG2022PTC159263.
R9 Pharma Technologies has 2 current directors:
- Ramalaxmareddy Kandimalla - Director
- Thoom Srividya - Director
The latest financial statements of R9 Pharma Technologies on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of R9 Pharma Technologies is U24290TG2022PTC159263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R9 Pharma Technologies was incorporated on 01 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ramalaxmareddy Kandimalla was appointed as Director on 01 Feb 2022. Thoom Srividya was appointed as Director on 01 Feb 2022.
The registered office of R9 Pharma Technologies is at CO.K Rama Laxma Reddy 11 – 13 – 189Ssr201 Ssr Leela Park Residency Krishi Nagar C, Hyderabad, Telangana, India – 500035.
R9 Pharma Technologies operates in the chemicals industry, in the manufacturing segment.
The compliance status of R9 Pharma Technologies is compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.
R9 Pharma Technologies can be reached at its registered office: CO.K Rama Laxma Reddy 11 – 13 – 189Ssr201 Ssr Leela Park Residency Krishi Nagar C, Hyderabad, Telangana, India – 500035.